Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
Biol Blood Marrow Transplant. 2012 Sep;18(9):1353-67. doi: 10.1016/j.bbmt.2012.06.017. Epub 2012 Jul 11.
Based on clinical observations that donor T cells specific for minor histocompatibility antigens (MiHA) ubiquitously expressed on both hematopoietic and nonhematopoietic cells were detected in patients showing evident graft-versus-leukemia/lymphoma (GVL) reactivity with no or limited coinciding graft-versus-host disease (GVHD), we hypothesized that nonhematopoietic tissues may be relatively unsusceptible to the cytotoxic effect of MiHA-specific T cells under normal, noninflammatory conditions. To test this hypothesis, we investigated the reactivity of alloreactive T cells specific for ubiquitously expressed MiHA against skin-derived primary human fibroblasts. We demonstrated that this reactivity was not merely determined by their antigen-specificity, but was highly dependent on adhesion molecule expression. ICAM-1 expression on the fibroblasts upregulated under proinflammatory conditions and induced during cross-talk with the T cells was demonstrated to be a crucial factor facilitating formation of high avidity interactions with the T cells and subsequent efficient target cell destruction. Furthermore, we provide supporting evidence for the role of ICAM-1 in vivo by demonstrating that ICAM-1 expression on nonhematopoietic target cells was dependent on the presence of infiltrating activated T cells, as was illustrated by restricted ICAM-1 expression at the sites of T cell infiltration in skin biopsies of patients with acute GVHD (aGVHD), by the absence of ICAM-1 expression in the same biopsies in areas without T cell infiltration and by the absence of ICAM-1 expression in biopsies of patients without GVHD independent of the presence of infiltrating nonactivated T cells. In conclusion, under noninflammatory conditions, nonhematopoietic tissues are unsusceptible to the GVHD reactivity of alloreactive T cells due to their inability to establish high avidity interactions.
基于临床观察,在表现出明显移植物抗白血病/淋巴瘤(GVL)反应而无或仅有有限的移植物抗宿主病(GVHD)的患者中,检测到针对广泛存在于造血和非造血细胞上的次要组织相容性抗原(MiHA)的供体 T 细胞。我们假设,在正常非炎症条件下,非造血组织可能相对不易受到 MiHA 特异性 T 细胞的细胞毒性作用。为了验证这一假设,我们研究了针对广泛表达的 MiHA 的同种反应性 T 细胞对皮肤来源的原代人成纤维细胞的反应性。我们证明,这种反应性不仅仅取决于其抗原特异性,还高度依赖于粘附分子的表达。在炎症条件下上调并在与 T 细胞相互作用过程中诱导的成纤维细胞上的 ICAM-1 表达被证明是促进与 T 细胞形成高亲和力相互作用并随后有效破坏靶细胞的关键因素。此外,我们通过提供支持证据表明 ICAM-1 在非造血靶细胞中的作用,表明非造血靶细胞上的 ICAM-1 表达取决于浸润的活化 T 细胞的存在,这在急性移植物抗宿主病(aGVHD)患者皮肤活检中 T 细胞浸润部位的 ICAM-1 表达受限、在没有 T 细胞浸润的相同活检部位缺乏 ICAM-1 表达以及在没有 GVHD 的患者的活检中缺乏 ICAM-1 表达中得到了证明,无论浸润的非活化 T 细胞的存在如何。总之,在非炎症条件下,非造血组织不易受到同种反应性 T 细胞的 GVHD 反应,因为它们无法建立高亲和力相互作用。